With increased attention to critical role of diversity, equity, inclusion, and accessibility (DEIA) for product development, this webinar hosted by IMPT for Reproductive Health, housed at the Public Health Institute, focuses on the importance of inclusion of diverse populations in clinical research. This aligns with new FDA guidelines and NIH priorities around DEIA.
